Gene	syn	non_syn	REF	ALT	POS	Genomic_coord_start	Genomic_coord_end	Main_ref_codon	Main_alt_codon	Main_ref_residue	Main_alt_residue	NbSample	MeanAF	MainFeat	MainResidue	SARS-Cov Residue	SecondResidue	SecondResidue	Second_ref_codon	Second_alt_codon	Second_ref_residue	Second_alt_residue	Third_ref_codon	Third_alt_codon	Third_ref_residue	Third_alt_residue	ORF1ab pos	Annotation	Impact	Reference
"ORF1a 16
leader protein 16
Genomic 311-313"					311	311	313	CTC(L)	CTT(L) 13 NNN(-) 2 CTY(L) 1 CTT(L) CTY(L) 1	L	L -			ORF1a	16		leader protein	16									16	leader protein		
"ORF1a 30,leader protein 30"	0	1	na	0	353	353	355	0	0	G	D	12	0	ORF1a	30	ORF1a 30	leader protein	30	na	na	na	na	na	na	na	na	30	leader protein		
"ORF1a 84,leader protein 84"	2	0	0	0	515	515	517	0	0	V		2		ORF1a	84		leader protein	84	na	na	na	na	na	na	na	na	84	leader protein		
"ORF1a 86
leader protein 86
Genomic 521-523"					521	521	523	ATG(M)	GTT(V) 1 GTT(V) NNN(-) 3) NNN(-) 1 GTT(V) NNT(MIX) 1	M	V V - M - V MIX			ORF1a	86		leader protein	86									86			
"ORF1a 92
leader protein 92
Genomic 539-541"					539	539	541	CTC(L)	CTT(L) 4 1 MTC(IL) 6 NNN(-) 2 NTC(ILVF) 1 CYC(PL) 1 CTC(L) TTC(F) 1 CTG(L) 1	L	L L IL L - L ILVF L PL L F L L			ORF1a	92		leader protein	92									92			
"ORF1a 135,leader protein 135"	0	0	0	0	668	668	670	0	0	S	N	5		ORF1a	135		leader protein	135	na	na	na	na	na	na	na	na	135	leader protein		
"ORF1a 166,leader protein 166"	0	1	na	0	761	761	763	0	0	S	G	4	0	ORF1a	166	ORF1a 166	leader protein	166	na	na	na	na	na	na	na	na	166			
"ORF1a 210
nsp2 30
Genomic 893-895"					893	893	895	AAA(K)	AAG(K) 2 1	K	K			ORF1a	210		nsp2	30									210	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		
"ORF1a 231,nsp2 51"	0	1	na	0	956	956	958	0	0	C	Y	3	0	ORF1a	231	ORF1a 231	nsp2	51	na	na	na	na	na	na	na	na	231	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 265,nsp2 85"	0	2	na	0	1058	1058	1060	acC	acT	T	T	12	0	ORF1a	265	ORF1a 265	nsp2	85	na	na	na	na	na	na	na	na	265	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 268,nsp2 88"	0	1	na	0	1067	1067	1069	0	0	G	E	4	0	ORF1a	268	ORF1a 268	nsp2	88	na	na	na	na	na	na	na	na	268	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 274
nsp2 94
Genomic 1085-1087"					1085	1085	1087	GTA(V)	GTG(V) 2	V	V			ORF1a	274		nsp2	94									274	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 286,nsp2 106"	0	0	0	0	1121	1121	1123			P		5		ORF1a	286		nsp2	106	na	na	na	na	na	na	na	na	286	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 333
nsp2 153
Genomic 1262-1264"					1262	1262	1264	ACG(T)	ATG(M) 3 ACG(T) ACT(T) 2 ACA(T) ACG(T) 2 ACG(T) GCG(A) 1	T	M T T T T T A			ORF1a	333		nsp2	153										"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"
"ORF1a 374,nsp2 194"	0	1	na	0	1385	1385	1387	0	0	H	Y	5	0	ORF1a	374	ORF1a 374	nsp2	194	na	na	na	na	na	na	na	na	374	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 392,nsp2 212"	0	1	na	0	1439	1439	1441	0	0	G	"D,C"	12	0	ORF1a	392	ORF1a 392	nsp2	212	na	na	na	na	na	na	na	na	392	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 398
nsp2 218
Genomic 1457-1459"					1457	1457	1459	CGT(R)	TGT(C) 3 2	R	C			ORF1a	398		nsp2	218										"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"
"ORF1a 428,nsp2 248"	0	1	na	0	1547	1547	1549	0	0	S	"G,N"	3	0	ORF1a	428	ORF1a 428	nsp2	248	na	na	na	na	na	na	na	na	428	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 454
nsp2 274
Genomic 1625-1627"					1625	1625	1627	CTC(L)	TTC(F) 1 1 CTC(L) NNN(-) 2	L	F L -			ORF1a	454		nsp2	274										"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 486
nsp2 306
Genomic 1721-1723"					1721	1721	1723	GCT(A)	GTT(V) 2 1 GCT(A) TCT(S) 1 GCT(A) GYT(AV) 1 GCT(A) NNN(-) 1	A	V A S A AV A -			ORF1a	486		nsp2	306										"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 519,nsp2 339"	0	3	na	0	1820	1820	1822	0	0	G	S	4	0	ORF1a	519	ORF1a 519	nsp2	339	na	na	na	na	na	na	na	na	519	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 580,nsp2 400"	0	1	na	0	2003	2003	2005	Att	Gtt	I	V	11	0	ORF1a	580	ORF1a 580	nsp2	400	na	na	na	na	na	na	na	na	580	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 609
nsp2 429
Genomic 2090-2092"					2090	2090	2092	ACT(T)	ATT(I) 1 2 ACT(T) AYT(TI) 4 ATT(I) AYT(TI) 1	T	I T TI I TI			ORF1a	609		nsp2	429										"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 650
nsp2 470
Genomic 2213-2215"					2213	2213	2215	AAA(K)	AAG(K) 3 AAA(K) AAC(N) 1 AAA(K) NNN(-) 1	K	K K N K -			ORF1a	650		nsp2	470										"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 652
nsp2 472
Genomic 2219-2221"					2219	2219	2221	ATC(I)	GTC(V) 1 ATC(I) NNN(-) 1	I	V I -			ORF1a	652		nsp2	472										"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 660,nsp2 480"	0	1	na	0	2243	2243	2245	gGt	gTt	G	V	5	0	ORF1a	660	ORF1a 660	nsp2	480	na	na	na	na	na	na	na	na	660	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 717
nsp2 537
Genomic 2414-2416"					2414	2414	2416	TAC(Y)	TAT(Y) 13 5 TAC(Y) TAY(Y) 4 TAT(Y) TAY(Y) 2 TAC(Y) TAN(Y) 1 NNN(-) TAC(Y) 1	Y	Y Y Y Y Y Y Y - Y			ORF1a	717		nsp2	537										"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 748 nsp2 568
Genomic 2507-2509"					2507	2507	2509	CCC(P)	CTC(L) 3 TCC(S) 2 CCT(P) 1	P	L S P			ORF1a	748		nsp2	568										"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 872
nsp3 54
Genomic 2879-2881"					2879	2879	2881	GCC(A)	GTC(V) 1 GCC(A) TCC(S) 1	A	V A S			ORF1a	872		nsp3	54									872			
"ORF1a 892,nsp3 74"	0	3	na	0	2939	2939	2941	0	0	P	"L,S"	2	0	ORF1a	892	ORF1a 893	nsp3	74	na	na	na	na	na	na	na	na	892	"PLpro, Glu-rich acidic acidic (AD) domain, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 894
nsp3 76
Genomic 2945-2947"					2945	2945	2947	AGC(S)	GGC(G) 1 1 GGC(G) TGC(C) 1 GGC(G) RGC(SG) 1	S	G G C G SG			ORF1a	894		nsp3	76									894			
"ORF1a 924,nsp3 106"	1	0	0	0	3035	3035	3037	ttC	ttT	F	F			ORF1a	924		nsp3	106	na	na	na	na	na	na	na	na	924	"PLpro, Glu-rich acidic acidic (AD) domain, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017, 10.1016/j.ygeno.2020.04.016"
"ORF1a 960,nsp3 142"	0	1	na	0	3143	3143	3145	0	0	L	"F,S"	11	0	ORF1a	960	ORF1a 962	nsp3	142	na	na	na	na	na	na	na	na	960	"PLpro, Glu-rich acidic acidic (AD)  domain, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1100,nsp3 282"	0	6	na	0	3563	3563	3565	0	0	G	V	3	0	ORF1a	1100	ORF1a 1078	nsp3	282	na	na	na	na	na	na	na	na	1100	"PLpro, X domain with poly(ADP-ribose) binding properties"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1143
nsp3 325
Genomic 3692-3694"					3692	3692	3694	GTT(V)	TTT(F) 2 GTT(V) KTT(VF) 2	V	F V VF			ORF1a	1143		nsp3	325									1143	"PLpro, X domain with poly(ADP-ribose) binding properties"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1158
nsp3 340
Genomic 3737-3739"					3737	3737	3739	CCT(P)	CTT(L) 3 2 CCT(P) TCT(S) 2 CTT(L) CYT(PL) 1	P	L P S L PL			ORF1a	1158		nsp3	340									1158	"PLpro, X domain with poly(ADP-ribose) binding properties"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1160
nsp3 342
Genomic 3743-3745"					3743	3743	3745	CAT(H)	TAT(Y) 1 2 CAN(QH) CAT(H) 1	H	Y QH H			ORF1a	1160		nsp3	342									1160	"PLpro, X domain with poly(ADP-ribose) binding properties"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1168
nsp3 350
Genomic 3767-3769"					3767	3767	3769	ACT(T)	ATT(I) 3 3 ATT(I) AYT(TI) 1 ACT(T) AYY(TI) 1	T	I I TI T TI			ORF1a	1168		nsp3	350									1168	"PLpro, X domain with poly(ADP-ribose) binding properties"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1202
nsp3 384
Genomic 3869-3871"					3869	3869	3871	AAG(K)	AAT(N) 1 2	K	N			ORF1a	1202		nsp3	384									1202	SUD Domain		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1208
nsp3 390
Genomic 3887-3889"					3887	3887	3889	AAA(K)	AAG(K) 2	K	K			ORF1a	1208		nsp3	390									1208	"SUDcore (for SARS-CoV Unique Domain, an insertion not found in any other coronavirus thus far) "		10.1371/journal.ppat.1000428
"ORF1a 1262, nsp3 444"	0	2	na	0	4049	4049	4051	Ctt	Ttt	L	F	2	0	ORF1a	1262	ORF1a 1238	nsp3	444	na	na	na	na	na	na	na	na	1262	"PLpro, SUDcore with a specific affinity for oligo(G)-strings , interacts with GST-nsp9, The N-terminal subdomain (SUD-N)"		"10.1128/jvi.00017-07, https://dx.plos.org/10.1371/journal.ppat.1000428, 10.1016/j.virusres.2007.11.017"
"ORF1a 1352
nsp3 534
Genomic 4319-4321"					4319	4319	4321	GCC(A)	GTC(V) 2 GCC(A) RCC(TA) 1 GCC(A) GCT(A) 1	A	V A TA A A			ORF1a	1352		nsp3	534									1352	"PLpro, SUDcore with a specific affinity for oligo(G)-strings , interacts with GST-nsp9. middle SUD subdomain (SUD-M)"		10.1371/journal.ppat.1000428
"ORF1a 1375,nsp3 557"	0	1	na	0	4388	4388	4390	0	0	L	F	6	0	ORF1a	1375	ORF1a 1351	nsp3	557	na	na	na	na	na	na	na	na	1375	"PLpro, SUDcore with a specific affinity for oligo(G)-strings , interacts with GST-nsp9. middle SUD subdomain (SUD-M)"		"10.1128/jvi.00017-07, https://dx.plos.org/10.1371/journal.ppat.1000428, 10.1016/j.virusres.2007.11.017"
"ORF1a 1415,nsp3 597"					4508		4510			V		2		ORF1a	1415		Nsp3	597									1415	"PLpro, SUDcore with a specific affinity for oligo(G)-strings , interacts with GST-nsp10. middle SUD subdomain (SUD-M)"		"10.1128/jvi.00017-07, https://dx.plos.org/10.1371/journal.ppat.1000428, 10.1016/j.virusres.2007.11.017"
"ORF1a 1464,nsp3 646"	0	1	na	0	4655	4655	4657	0	0	R	P	4	0	ORF1a	1464	ORF1a 1464	nsp3	646	na	na	na	na	na	na	na	na	1464	"PLpro, SUDcore with a specific affinity for oligo(G)-strings , interacts with GST-nsp9. middle SUD subdomain (SUD-M)"		"10.1128/jvi.00017-07, https://dx.plos.org/10.1371/journal.ppat.1000428, 10.1016/j.virusres.2007.11.017"
"ORF1a 1599,nsp3 781"	0	1	na	0	5060	5060	5062	0	0	L	F	11	0	ORF1a	1599	ORF1a 1576	nsp3	781	na	na	na	na	na	na	na	na	1599	"PLpro, papain-like proteinase (PLP2) domain, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1640
nsp3 822
Genomic 5183-5185"					5183	5183	5185	CCT(P)	TCT(S) 2 2 CCT(P) CTT(L) 5 1 CCT(P) CNN(MIX) 7 CCT(P) CYT(PL) 1	P	S P L P MIX P PL			ORF1a	1640		nsp3	822									1640	"PLpro, PLP2 domain, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1781,nsp3 963"	0	0	0	0	5606	5606	5608			K		5			1781		nsp3	963	na	na	na	na	na	na	na	na	1781	"PLpro, PLP2 domain, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1822
nsp3 1004
Genomic 5729-5731"					5729	5729	5731	ACT(T)	ATT(I) 4 3 A-T(NTSI) ACT(T) 1	T	I A-T(NTSI) T			ORF1a	1822		nsp3	1004									1822	"PLpro, PLP2 domain, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1840
nsp3 1022
Genomic 5783-5785"					5783	5783	5785	ACT(T)	ATT(I) 2 ACT(T) AYT(TI) 1	T	I T TI			ORF1a	1840		nsp3	1022									1840	"PLpro, PLP2 domain, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1921
nsp3 1103
Genomic 6026-6028"					6026	6026	6028	CCA(P)	CTA(L) 1 2 CCA(P) TCA(S) 3 1	P	L P S			ORF1a	1921		nsp3	1103									1921	"PLpro, PLP2 domain, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1997,nsp3 1179"	0	2	na	0	6254	6254	6256	0	0	A	V	2	0	ORF1a	1997	ORF1a 1974	nsp3	1179	na	na	na	na	na	na	na	na	1997	"PLpro, PLP2 domain, papain-like noncanonical (PLnc), exhibit deubiquitinating activity, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2016,nsp3 1198"	0	2	na	0	6311	6311	6313	0	0	T	I	4	0	ORF1a	2016	ORF1a 1993	nsp3	1198	na	na	na	na	na	na	na	na	2016	"PLpro, PLP2 domain, papain-like noncanonical (PLnc), exhibit deubiquitinating activity, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2062
nsp3 1244
Genomic 6449-6451"					6449	6449	6451	CTT(L)	TTT(F) 1 2 CTT(L) CTY(L) 1 CTT(L) NTT(ILVF) 1	L	F L L L ILVF			ORF1a	2062		nsp3	1244									2062	"PLpro, PLnc domain"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2067
nsp3 1249
Genomic 6464-6466"					6464	6464	6466	AAA(K)	AAG(K) 1 1	K	K			ORF1a	2067		nsp3	1249									2067	"PLpro, PLnc domain"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2098
nsp3 1280
Genomic 6557-6559"					6557	6557	6559	GCT(A)	GTT(V) 1 2	A	V			ORF1a	2098		nsp3	1280									2098	"PLpro, PLnc domain"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2124,nsp3 1306"	0	2	na	0	6635	6635	6637	Cat	Tat	H	Y	4	0	ORF1a	2124	ORF1a 2101	nsp3	1306	na	na	na	na	na	na	na	na	2124	"PLpro, papain-like noncanonical (PLnc)"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2144,nsp3 1326"	0	2	na	0	6695	6695	6697	0	0	P	"L,T,S"	3	0	ORF1a	2144	ORF1a 2121	nsp3	1326	na	na	na	na	na	na	na	na	2144	"PLpro, papain-like noncanonical (PLnc) domain, interacts with GST-nsp9 , "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2153,nsp3 1335"	0	2	na	0	6722	6722	6724	0	0	T	I	2	0	ORF1a	2153	ORF1a 2130	nsp3	1335	na	na	na	na	na	na	na	na	2153	"PLpro, papain-like noncanonical (PLnc)"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2242,nsp3 1424"	0	2	na	0	6989	6989	6991	0	0	S	F	3	0	ORF1a	2242	ORF1a 2219	nsp3	1424	na	na	na	na	na	na	na	na	2242	"PLpro, Y domain, transmembrane domain, interacts with GST-nsp9 , Y domain has “no obvious role in RNA synthesis. Therefore, it is logical to propose that they may rather play a role in virus-host interactions to, e.g. modulate immunity and/or pathogenesis.”"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2249,nsp3 1431"	0	2	na	0	7010	7010	7012	0	0	A	V	10	0	ORF1a	2249	2226	nsp3	1431	na	na	na	na	na	na	na	na	2249	"PLpro, Y domain, transmembrane domain, interacts with GST-nsp9 , Y domain has “no obvious role in RNA synthesis. Therefore, it is logical to propose that they may rather play a role in virus-host interactions to, e.g. modulate immunity and/or pathogenesis.”"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2405
nsp3 1587
Genomic 7478-7480"					7478	7478	7480	AAT(N)	AGT(S) 2 AAT(N) NNN(-) 2 AGT(S) ART(NS) 1	N	S N - S NS			ORF1a	2405	2382	nsp3	1587									2405	"PLpro, Catalytic domain, Y domain, Y domain has “no obvious role in RNA synthesis. Therefore, it is logical to propose that they may rather play a role in virus-host interactions to, e.g. modulate immunity and/or pathogenesis.”"		"10.1002/cmdc.202000223, 10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2470
nsp3 1652
Genomic 7673-7675"					7673	7673	7675	GCG(A)	GCT(A) 4	A	A			ORF1a	2470	2447	nsp3	1652									2470	"PLpro, Catalytic domain, Y domain, Y domain has “no obvious role in RNA synthesis. Therefore, it is logical to propose that they may rather play a role in virus-host interactions to, e.g. modulate immunity and/or pathogenesis.”"		"10.1002/cmdc.202000223, 10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2497
nsp3 1679
Genomic 7754-7756"					7754	7754	7756	AAG(K)	AAT(N) 1 AAG(K) AGG(R) 1 A-G(KTRM) AAG(K) 1	K	N K R A-G(KTRM) K			ORF1a	2497	2474	nsp3	1679									2497	"PLpro, Catalytic domain, Y domain, Y domain has “no obvious role in RNA synthesis. Therefore, it is logical to propose that they may rather play a role in virus-host interactions to, e.g. modulate immunity and/or pathogenesis.”"		"10.1002/cmdc.202000223, 10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2500
nsp3 1682
Genomic 7763-7765"					7763	7763	7765	TCC(S)	TCT(S) 2 4 TCC(S) TTC(F) 2	S	S S F			ORF1a	2500	2477	nsp3	1682									2500	"PLpro, Catalytic domain, Y domain, Y domain has “no obvious role in RNA synthesis. Therefore, it is logical to propose that they may rather play a role in virus-host interactions to, e.g. modulate immunity and/or pathogenesis.”"		"10.1002/cmdc.202000223, 10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2557
nsp3 1739
Genomic 7934-7936"					7934	7934	7936	GCG(A)	GCT(A) 3 1 GCG(A) GCR(A) 1	A	A A A			ORF1a	2557	2534	nsp3	1739									2557	"PLpro, Catalytic domain, Y domain, Y domain has “no obvious role in RNA synthesis. Therefore, it is logical to propose that they may rather play a role in virus-host interactions to, e.g. modulate immunity and/or pathogenesis.”"		"10.1002/cmdc.202000223, 10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2635
nsp3 1817
Genomic 8168-8170"					8168	8168	8170	TCA(S)	TCG(S) 2	S	S			ORF1a	2635	2612	nsp3	1817									2635	"PLpro, Catalytic domain, Y domain, Y domain has “no obvious role in RNA synthesis. Therefore, it is logical to propose that they may rather play a role in virus-host interactions to, e.g. modulate immunity and/or pathogenesis.”"		"10.1002/cmdc.202000223, 10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2796
nsp4 33
Genomic 8651-8653"					8651	8651	8653	ATG(M)	CTG(L) 2 2 ATG(M) ATT(I) 2 ATG(M) NNN(-) 7 ATG(M) MTG(ML) 3 ATC(I) ATT(I) 1 ANN(MIX) ATG(M) 1 ATG(M) GTG(V) 1	M	L M I M - M ML I I MIX M M V			ORF1a	2796	2773	nsp4	33									2796			
"ORF1a 2842,nsp4 79"	0	2	na	0	8789	8789	8791	0	0	G	V	3	0	ORF1a	2842	ORF1a 2819	nsp4	79	na	na	na	na	na	na	na	na	2842			
"ORF1a 2949,nsp4 186"	0	1	na	0	9110	9110	9112	0	0	R	H	6	0	ORF1a	2949	2926	nsp4	186	na	na	na	na	na	na	na	na	2949			
"ORF1a 3027
nsp4 264
Genomic 9344-9346"					9344	9344	9346	CTT(L)	TTT(F) 1 2	L	F			ORF1a	3027		nsp4	264									3027			
"ORF1a 3058
nsp4 295
Genomic 9437-9439"					9437	9437	9439	ACA(T)	ATA(I) 6 3 ACA(T) TCA(S) 1 ACA(T) AYA(TI) 1	T	I T S T TI			ORF1a	3058		nsp4	295									3058			
"ORF1a 3070
nsp4 307
Genomic 9473-9475"					9473	9473	9475	GCT(A)	GTT(V) 4 3 GCT(A) GNT(DAGV) 2 GCN(A) GCT(A) 2 GCT(A) GYT(AV) 1 GCT(A) GCW(A) 1 GTT(V) GYT(AV) 1	A	V A DAGV A A A AV A A V AV			ORF1a	3070		nsp4	307									3070			
"ORF1a 3071
nsp4 308
Genomic 9476-9478"					9476	9476	9478	TAT(Y)	TTT(F) 1 2 NTT(ILVF) TTT(F) 1	Y	F ILVF F			ORF1a	3071		nsp4	308									3071			
"ORF1a 3072
nsp4 309
Genomic 9479-9481"					9479	9479	9481	GGT(G)	TGT(C) 2 2 GGT(G) KGT(GC) 2 TGT(C) WGT(SC) 1	G	C G GC C SC			ORF1a	3072		nsp4	309									3072			
"ORF1a 3076
nsp4 313
Genomic 9491-9493"					9491	9491	9493	CAT(H)	TAT(Y) 5 2 CAT(H) YAT(HY) 1	H	Y H HY			ORF1a	3076		nsp4	313									3076			
"ORF1a 3090
nsp4 327
Genomic 9533-9535"					9533	9533	9535	AAT(N)	ACT(T) 1 ACT(T) ATT(I) 1 ACT(T) NNN(-) 1	N	T T I T -			ORF1a	3090		nsp4	327									3090			
"ORF1a 3227
nsp4 464
Genomic 9944-9946"					9944	9944	9946	AGA(R)	AGG(R) 2 AGA(R) AGW(RS) 1	R	R R RS			ORF1a	3227		nsp4	464									3227			
"ORF1a 3278
3C-like proteinase 15
Genomic 10097-10099"					10097	10097	10099	AGT(S)	GGT(G) 4 2 AGT(S) NGT(SRGC) 1 GAT(D) GGT(G) 1	S	G S SRGC D G			ORF1a	3278		3C like proteinase	15									2778	Two beta barrel Catalytic fold 		10.1021/bi0616302
"ORF1a 3308
3C-like proteinase 45
Genomic 10187-10189"					10187	10187	10189	ACC(T)	ATC(I) 1 1	T	I			ORF1a	3308		3C like proteinase	45									2808	Two beta barrel Catalytic fold 		10.1021/bi0616302
"ORF1a 3323
3C-like proteinase 60
Genomic 10232-10234"					10232	10232	10234	CGT(R)	TGT(C) 2	R	C			ORF1a	3323		3C like proteinase	60									2823	Two beta barrel Catalytic fold 		10.1021/bi0616302
"ORF1a 3353,3C-like proteinase 90"	0	3	na	0	10322	10322	10324	aaG	aaT	K	N	8	0	ORF1a	3353	ORF1a 3330	3C-like proteinase	90	na	na	na	na	na	na	na	na	3353	Two beta barrel Catalytic fold 		"10.1016/j.pbiomolbio.2018.08.009, 10.1021/bi0616302"
"ORF1a 3357
3C-like proteinase 94
Genomic 10334-10336"					10334	10334	10336	GCC(A)	GTC(V) 1 1	A	V			ORF1a	3357		3C like proteinase	94									3357	"Variable position between SARS(S) and SARS2(A), Two beta barrel Catalytic fold  "		10.12688/f1000research.22457.2
"ORF1a 3447
3C-like proteinase 184
Genomic 10604-10606"					10604	10604	10606	CCT(P)	TCT(S) 2 CCN(P) CCT(P) 2 CCT(P) CTT(L) 1	P	S P P P L			ORF1a	3447		3C like proteinase	184									3447	Two beta barrel Catalytic fold 		10.1021/bi0616302
"ORF1a 3483,3C-like proteinase 220"	0	1	na	0	10712	10712	10714	0	0	L	F	10	0	ORF1a	3483	ORF1a 3460	3C-like proteinase	220	na	na	na	na	na	na	na	na	3483	Globular domain		10.1021/bi0616302
"ORF1a 3497
3C-like proteinase 234
Genomic 10754-10756"					10754	10754	10756	ACT(T)	GCT(A) 1 GCT(A) GTT(V) 1	T	A A V			ORF1a	3497		3C like proteinase	234									3497	Globular domain		10.1021/bi0616302
"ORF1a 3512
3C-like proteinase 249
Genomic 10799-10801"					10799	10799	10801	ATA(I)	ATT(I) 1	I	I			ORF1a	3512		3C like proteinase	249									3512	Globular domain		10.1021/bi0616302
"ORF1a 3542
3C-like proteinase 279
Genomic 10889-10891"					10889	10889	10891	CGT(R)	TGT(C) 2	R	C			ORF1a	3542		3C like proteinase	279									3542	Globular domain		10.1021/bi0616302
"ORF1a 3580
nsp6 11
Genomic 11003-11005"					11003	11003	11005	CAC(H)	TAC(Y) 1 GAC(D) TAC(Y) 1	H	Y D Y			ORF1a	3580		nsp6	11									3580			
"ORF1a 3603,nsp6 34"	6	0	0	0	11072	11072	11074	Ttt	"Ctt,ttT"	F	"L,F"	10		ORF1a	3603		nsp6	34	na	na	na	na	na	na	na	na	3603			
"ORF1a 3606,nsp6 37"	0	7	na	0	11081	11081	11083	ttG	ttT	L	F	12	0	ORF1a	3606	ORF1a 3583	nsp6	37	na	na	na	na	na	na	na	na	3606	Identified mutation		"10.1186/s12967-020-02344-6, 10.1016/j.ygeno.2020.04.016"
"ORF1a 3639
nsp6 70
Genomic 11180-11182"					11180	11180	11182	TTC(F)	TTT(F) 2 1	F	F			ORF1a	3639		nsp6	70									3639			
"ORF1a 3644
nsp6 75
Genomic 11195-11197"					11195	11195	11197	CTT(L)	TTT(F) 2 2	L	F			ORF1a	3644		nsp6	75									3644			
"ORF1a 3714,nsp6 145"	0	1	na	0	11405	11405	11407	0	0	V	I	7	0	ORF1a	3714	ORF1a 3691	nsp6	145	na	na	na	na	na	na	na	na	3714	Epitope HLA locus A group 2 subtype 2:01		10.1101/2020.03.30.016931
"ORF1a 3725
nsp6 156
Genomic 11438-11440"					11438	11438	11440	AAT(N)	GAT(D) 1 AAT(N) AGT(S) 1	N	D N S			ORF1a	3725		nsp6	156									3725			
"ORF1a 3755,nsp6 186"	0	1	na	0	11528	11528	11530	0	0	A	T	7	0	ORF1a	3755	ORF1a 3732	nsp6	186	na	na	na	na	na	na	na	na	3755			
"ORF1a 3757,nsp6 188"	0	3	na	0	11534	11534	11536	0	0	G	"V,S"	3	0	ORF1a	3757	ORF1a 3734	nsp6	188	na	na	na	na	na	na	na	na	3757			
"ORF1a 3777
nsp6 208
Genomic 11594-11596"					11594	11594	11596	CAG(Q)	CGG(R) 1 1 CAG(Q) CAT(H) 1 CAG(Q) CRG(QR) 1	Q	R Q H Q QR			ORF1a	3777		nsp6	208									3777			
"ORF1a 3839,nsp6 270"	0	0	0	0	11780	11780	11782			K	R	2		ORF1a	3839		nsp6	270	na	na	na	na	na	na	na	na	3839			
"ORF1a 3856
nsp6 287
Genomic 11831-11833"					11831	11831	11833	ACC(T)	GCC(A) 1 GCC(A) GTC(V) 1 GCC(A) GCT(A) 1 GCC(A) TCC(S) 1 GCC(A) GCN(A) 1 GCC(A) GCY(A) 1	T	A A V A A A S A A A A			ORF1a	3856		nsp6	287									3856			
"ORF1a 3858
nsp6 289
Genomic 11837-11839"					11837	11837	11839	GTA(V)	GTG(V) 2 1 GTA(V) NNN(-) 1 GTA(V) TTA(L) 1 GTA(V) KTA(VL) 1	V	V V - V L V VL			ORF1a	3858		nsp6	289									3858			
"ORF1a 3899
nsp7 40
Genomic 11960-11962"					11960	11960	11962	CTC(L)	CTT(L) 5 1 CTC(L) TTC(F) 1 ATC(I) CTC(L) 1	L	L L F I L			ORF1a	3899		nsp7	40										Helix HB2 		10.1038/nsmb999. 10.1038/s41467-019-10280-3
"ORF1a 3958
nsp8 16
Genomic 12137-12139"					12137	12137	12139	GCT(A)	GTT(V) 2	A	V			ORF1a	3958		nsp8	16										"Chain G, ‘shaft N-ter domain’"		10.1038/nsmb999. 10.1038/s41467-019-10280-3
"ORF1a 3983
nsp8 41
Genomic 12212-12214"					12212	12212	12214	TCT(S)	TTT(F) 2 2	S	F			ORF1a	3983		nsp8	41										"Chain G, ‘shaft N-ter domain’"		10.1038/nsmb999. 10.1038/s41467-019-10280-3
"ORF1a 4097
nsp8 155
Genomic 12554-12556"					12554	12554	12556	GAA(E)	GAG(E) 2	E	E			ORF1a	4097		nsp8	155										"Chain H, ‘head’ C-ter domain"		10.1038/nsmb999. 10.1038/s41467-019-10280-3
"ORF1a 4177
nsp9 37
Genomic 12794-12796"					12794	12794	12796	GGA(G)	GGC(G) 1 GGA(G) TGT(C) 1 GGA(G) GGG(G) 1	G	G G C G G			ORF1a	4177		nsp9	37										RNA-Binding protein		10.1038/nsmb999
"ORF1a 4220
nsp9 80
Genomic 12923-12925"					12923	12923	12925	CCT(P)	TCT(S) 1 1 ACT(T) CCT(P) 1 CCT(P) YCT(PS) 1	P	S T P P PS			ORF1a	4220		nsp9	80										RNA-Binding protein		10.1038/nsmb999
"ORF1a 4379
nsp10 126
Genomic 13400-13402"					13400	13400	13402	TAT(Y)	TTA(L) 1 NNN(-) TAT(Y) 19 TAN(Y) TAT(Y) 4 NAT(NHDY) TAT(Y) 3 TAK(Y) TAT(Y) 3 TAT(Y) TAW(Y) 1	Y	L - Y Y Y NHDY Y Y Y Y Y			ORF1a	4379		nsp10	126												
"ORF1a 4381
nsp10 128
Genomic 13406-13408"					13406	13406	13408	TGG(W)	TGT(C) 1 1 TGC(C) TGT(C) 1 CTG(L) TGG(W) 1 TGK(WC) TGT(C) 3 TGN(CW) TGT(C) 1	W	C C C L W WC C CW C			ORF1a	4381		nsp10	128												
"ORF1a 4389
nsp10 136
Genomic 13430-13432"					13430	13430	13432	CCC(P)	TCC(S) 2 ACC(T) CCC(P) 1	P	S T P			ORF1a	4389		nsp10	136												
"ORF1b 15,RdRp 25"	0	3	na	0	13513	13513	13515	0	0	G	"Y,C"	6	0	ORF1b	15	"RdRp 25, ORF1a 4372"	RdRp	25	na	na	na	na	na	na	na	na	4395	"NiRAN, NTD ()N terminal Domain)"		"10.1371/journal.ppat.1000428, 10.1126/science.abb7498, 10.1093/nar/gkg916"
"ORF1b 53,RdRp 63"	0	1	na	0	13627	13627	13629	Gac	Tac	D	Y	10	0	ORF1b	53	"RdRp 63, ORF1a 4410"	RdRp	63	na	na	na	na	na	na	na	na	4433	"NiRAN, NTD"		"10.1371/journal.ppat.1000428, 10.1016/j.virusres.2017.01.023, 10.1126/science.abb7498 10.1093/nar/gkg916"
"ORF1b 87,RdRp 97"	0	2	na	0	13729	13729	13731	gCt	gTt	A	V	7	0	ORF1b	87	"RdRp 97, ORF1a 4444"	RdRp	97	na	na	na	na	na	na	na	na	4467	"NiRAN, NTD,  RNA interaction in RNA binding channel"		"10.1371/journal.ppat.1000428, 10.1126/science.abb7498 10.1093/nar/gkg916, 10.1074/jbc.ra120.013679"
"ORF1b 118
RdRp 128
Genomic 13822-13824"					13822	13822	13824	ATC(I)	GTC(V) 1 1	I	V			ORF1b	118	"RdRp	128, , ORF1a "	RdRp	128									4498	"NiRAN, NTD"		"10.1371/journal.ppat.1000428, 10.1126/science.abb7498 10.1093/nar/gkg916"
"ORF1b 151
RdRp 161
Genomic 13921-13923"					13921	13921	13923	GAC(D)	TAC(Y) 1 GAC(D) GTC(V) 1 KAC(DY) TAC(Y) 1	D	Y D V DY Y			ORF1b	151	"RdRp	161 , ORF1a "	RdRp	161									4531	"NiRAN, NTD"		"10.1371/journal.ppat.1000428, 10.1126/science.abb7498 10.1093/nar/gkg916"
"ORF1b 159,RdRp 169"	1	0	0	0	13945	13945	13947			P	ORF1b	8			159	"RdRp	169, ORF1a "	RdRp	169	na	na	na	na	na	na	na	na	4539	"NiRAN, NTD"		10.1126/science.abb7498 10.1093/nar/gkg916
"ORF1b 166
RdRp 176
Genomic 13966-13968"					13966	13966	13968	ACC(T)	GCC(A) 1	T	A			ORF1b	166	"RdRp	176, ORF1a "	RdRp	176									4546	"NiRAN, NTD"		10.1093/nar/gkg916
"ORF1b 212
RdRp 222
Genomic 14104-14106"					14104	14104	14106	CTC(L)	TTC(F) 1	L	F			ORF1b	212	"RdRp	222, ORF1a "	RdRp	222									4592	"NiRAN, NTD"		10.1093/nar/gkg916
"ORF1b 242,RdRp 252"	0	1	na	0	14194	14194	14196	Act	Gct	T	A	2	0	ORF1b	242	"RdRp 252, ORF1a 4599"	RdRp	252	na	na	na	na	na	na	na	na	4622	"Interface domain, NTD"		10.1038/s41467-019-10280-3 10.1093/nar/gkg916
"ORF1b 257
RdRp 267
Genomic 14239-14241"					14239	14239	14241	AAG(K)	AAT(N) 2	K	N			ORF1b	257	"RdRp	267, ORF1a "	RdRp	267									4637	"Interface domain, NTD"		10.1038/s41467-019-10280-3 10.1093/nar/gkg916
"ORF1b 266
RdRp 276
Genomic 14266-14268"					14266	14266	14268	ACG(T)	ATG(M) 1	T	M			ORF1b	266	"RdRp	276, ORF1a "	RdRp	276									4646	"Interface domain, NTD"		10.1038/s41467-019-10280-3 10.1093/nar/gkg916
"ORF1b 274
RdRp 284
Genomic 14290-14292"					14290	14290	14292	GAC(D)	TAC(Y) 1	D	Y			ORF1b	274	"RdRp	284, ORF1a "	RdRp	284									4654	"Interface domain, NTD"		10.1038/s41467-019-10280-3 10.1093/nar/gkg916
"ORF1b 313,RdRp 323"	0	2	na	0	14407	14407	14409	cCt	cTt	P	L	11	0	ORF1b	313	RdRp 323 ORF1ab 4670	RdRp	323	na	na	na	na	na	na	na	na	4693	"Interface domain, Observed stable mutation in Europe (mostly) and North America, NTD"		"10.1186/s12967-020-02344-6, 10.1038/s41467-019-10280-3, 10.1016/j.ygeno.2020.04.016 10.1093/nar/gkg916"
"ORF1b 395
RdRp 405
Genomic 14653-14655"					14653	14653	14655	GTT(V)	TTT(F) 1 1 ATT(I) GTT(V) 1	V	F I V			ORF1b	395	"RdRp	405, ORF1a "	RdRp	405									4775	"C-ter portion, “right hand” RdRp domain, Fingers Domain"		"10.1093/nar/gkg916, 10.1126/science.abb7498, 10.1093/nar/gkg916"
"ORF1b 418
RdRp 428
Genomic 14722-14724"					14722	14722	14724	TTC(F)	TTT(F) 3 2 TTC(F) TTY(F) 2	F	F F F			ORF1b	418	"RdRp	428, ORF1a "	RdRp	428									4798	"C-ter portion, “right hand” RdRp domain, Fingers Domain"		"10.1093/nar/gkg916, 10.1126/science.abb7498, 10.1093/nar/gkg916"
"ORF1b 445
RdRp 455
Genomic 14803-14805"					14803	14803	14805	TAC(Y)	TAT(Y) 11 4 TAC(Y) TAY(Y) 12 TAT(Y) TAY(Y) 1 TAC(Y) TAN(Y) 1 NNC(MIX) TAC(Y) 1	Y	Y Y Y Y Y Y Y MIX Y			ORF1b	445	"RdRp	455, ORF1a "	RdRp	455									4825	"C-ter portion, “right hand” RdRp domain, Fingers Domain"		"10.1093/nar/gkg916, 10.1126/science.abb7498, 10.1093/nar/gkg916"
"ORF1b 462
RdRp 472
Genomic 14854-14856"					14854	14854	14856	GTA(V)	GTG(V) 1 GTA(V) NNN(-) 1 GTA(V) GTT(V) 1	V	V V - V V			ORF1b	462	"RdRp	472, ORF1a "	RdRp	472									4842	"C-ter portion, Domain G (Positioning of template overhang), “right hand” RdRp domain"		"10.1093/nar/gkg916, 10.1126/science.abb7498"
"ORF1b 490
RdRp 500
Genomic 14938-14940"					14938	14938	14940	AAA(K)	AAG(K) 1 1 AAA(K) NAA(KQE) 1	K	K K KQE			ORF1b	490	"RdRp	500, ORF1a "	RdRp	500									4870	"C-ter portion, Fingers Domain,  Interaction with RNA, “right hand” RdRp domain"		"10.1093/nar/gkg916, 10.1038/s41586-020-2368-8, 10.1126/science.abb7498"
"ORF1b 566
RdRp 576
Genomic 15166-15168"					15166	15166	15168	CTG(L)	TTG(L) 3 1 TTG(L) TTR(L) 1 CTG(L) YTG(L) 1	L	L L L L L			ORF1b	566	"RdRp	576, ORF1a "	RdRp	576									4946	"C-ter portion, Fingers Domain, “right hand” RdRp domain"		"10.1093/nar/gkg916, 10.1038/s41586-020-2368-8, 10.1126/science.abb7498"
"ORF1b 603,RdRp 613"	0	1	na	0	15277	15277	15279	Cac	Tac	H	Y	10	0	ORF1b	603	"RdRp 613, ORF1a 4960"	RdRp	613	na	na	na	na	na	na	na	na	4983	"RdRp domain; Palm domain, A motif, tested for resistance to ntp analogues antiviral, no impact., C-ter portion, “right hand” RdRp domain"		"10.1128/JVI.00080-16, 10.1126/science.abb7498, 10.1038/s41467-019-10280-3 10.1093/nar/gkg916, 10.1126/science.abb7498"
"ORF1b 618
RdRp 628
Genomic 15322-15324"					15322	15322	15324	AAC(N)	AAT(N) 17 6 AAC(N) AAY(N) 3 AAT(N) AAY(N) 1	N	N N N N N			ORF1b	618	"RdRp	628, ORF1a "	RdRp	628									4998	"RdRp domain;, C-ter portion; Palm domain, “right hand” RdRp domain"		"10.1126/science.abb7498, 10.1038/s41467-019-10280-3 10.1093/nar/gkg916, 10.1038/s41586-020-2368-8, 10.1126/science.abb7498"
"ORF1b 637
RdRp 647
Genomic 15379-15381"					15379	15379	15381	AGC(S)	ATC(I) 5 1 AGC(S) AKC(SI) 2 ANC(NTSI) ATC(I) 1	S	I S SI NTSI I			ORF1b	637	"RdRp	647, ORF1a "	RdRp	647									5017	"RdRp domain; C-ter portion; Palm domain, “right hand” RdRp domain"		"10.1126/science.abb7498, 10.1038/s41467-019-10280-3 10.1093/nar/gkg916, 10.1038/s41586-020-2368-8, 10.1126/science.abb7498"
"ORF1b 652
RdRp 662
Genomic 15424-15426"					15424	15424	15426	GTA(V)	GTG(V) 1 1	V	V			ORF1b	652	"RdRp	662, ORF1a "	RdRp	662									5032	"RdRp domain; C-ter portion; Palm domain, “right hand” RdRp domain"		"10.1126/science.abb7498, 10.1038/s41467-019-10280-3 10.1093/nar/gkg916, 10.1038/s41586-020-2368-8, 10.1126/science.abb7498"
"ORF1b 746,RdRp 756"	0	0	0	0	15706	15706	15708			M	I	4		ORF1b	746	"RdRp	756, ORF1a "	RdRp	756	na	na	na	na	na	na	na	na	5126	"RdRp domain; Palm;, C-ter portion, C Domain, “right hand” RdRp domain"		"10.1126/science.abb7498, 10.1038/s41467-019-10280-3 10.1093/nar/gkg916"
"ORF1b 870
RdRp 880
Genomic 16078-16080"					16078	16078	16080	ATC(I)	GTC(V) 1 GTC(V) NNN(-) 1	I	V V -			ORF1b	870	"RdRp	880, ORF1a "	RdRp	880									5250	"C-ter portion, “right hand” RdRp domain"		"10.1093/nar/gkg916, 10.1126/science.abb7498"
"ORF1b 1022,helicase 100"	0	1	na	0	16534	16534	16536	0	0	S	"I,G"	12	0	ORF1b	1022	"helicase 100, ORF1a  5402"	helicase	100	na	na	na	na	na	na	na	na	5425	superfamily 1 helicase		10.3389/fmicb.2019.01813 10.1093/nar/gkg916
"ORF1b 1098
helicase 176
Genomic 16762-16764"					16762	16762	16764	CTT(L)	TTT(F) 1 2 CTT(L) YTT(LF) 1	L	F L LF			ORF1b	1098		helicase	176									5501	superfamily 1 helicase		10.3389/fmicb.2019.01813 10.1093/nar/gkg916
"ORF1b 1175
helicase 253
Genomic 16993-16995"					16993	16993	16995	CAC(H)	TAC(Y) 1	H	Y			ORF1b	1175		helicase	253									5578	superfamily 1 helicase		10.3389/fmicb.2019.01813 10.1093/nar/gkg916
"ORF1b 1218
helicase 296
Genomic 17122-17124"					17122	17122	17124	GCT(A)	TCT(S) 1 1 ACT(T) GCT(A) 1	A	S T A			ORF1b	1218		helicase	296									5621	superfamily 1 helicase		10.3389/fmicb.2019.01813 10.1093/nar/gkg916
"ORF1b 1219,helicase 297"	0	1	na	0	17125	17125	17127	0	0	L	"P,F,I"	4	0	ORF1b	1219	"helicase 297, ORF1a  5599"	helicase	297	na	na	na	na	na	na	na	na	5622	superfamily 1 helicase		10.3389/fmicb.2019.01813
"ORF1b 1241,helicase 319"	0	2	na	0	17191	17191	17193	tgT	tgC	C	C	2	0	ORF1b	1241	"helicase 319, ORF1a 5621"	helicase	319	na	na	na	na	na	na	na	na	5644	superfamily 1 helicase		10.3389/fmicb.2019.01813
"ORF1b 1259,helicase 337"	1	0	0	0	17245	17245	17247			R		4		ORF1b	1259		helicase	337	na	na	na	na	na	na	na	na	5662	superfamily 1 helicase		10.3389/fmicb.2019.01813
"ORF1b 1270,helicase 348"	0	1	na	0	17278	17278	17280	0	0	V	L	7	0	ORF1b	1270	"helicase 348, ORF1a 5650"	helicase	348	na	na	na	na	na	na	na	na	5673	superfamily 1 helicase		10.3389/fmicb.2019.01813
"ORF1b 1426,helicase 504"	0	2	na	0	17746	17746	17748	cCt	cTt	P	L	2	0	ORF1b	1426	"helicase 504, ORF1ab 5806"	helicase	504	na	na	na	na	na	na	na	na	5829	"North America Mutation. other mutations more likely to appear, superfamily 1 helicase"		"10.1186/s12967-020-02344-6; 10.3389/fmicb.2019.01813, 10.1016/j.ygeno.2020.04.016, "
"ORF1b 1432
helicase 510
Genomic 17764-17766"					17764	17764	17766	GTC(V)	GTT(V) 5 1 GTC(V) GTY(V) 1	V	V V V			ORF1b	1432		helicase	510									5835	superfamily 1 helicase		10.3389/fmicb.2019.01813
"ORF1b 1443,helicase 521"	0	0	0	0	17797	17797	17799			V		5		ORF1b	1443		helicase	521	na	na	na	na	na	na	na	na	5846	superfamily 1 helicase		10.3389/fmicb.2019.01813
"ORF1b 1452,helicase 530"	0	1	na	0	17824	17824	17826	aCt	aTt	T	I	2	0	ORF1b	1452	"helicase 530, ORF1a 5832"	helicase	530	na	na	na	na	na	na	na	na	5855	superfamily 1 helicase		10.3389/fmicb.2019.01813
"ORF1b 1472,helicase 550"	0	1	na	0	17884	17884	17886	0	0	T	A	3	0	ORF1b	1472	"helicase 550, ORF1a 5852"	helicase	550	na	na	na	na	na	na	na	na	5875	superfamily 1 helicase		10.3389/fmicb.2019.01813
"ORF1b 1538
3'-to-5' exonuclease 15
Genomic 18082-18084"					18082	18082	18084	ACC(T)	ATC(I) 1 ATC(I) GTC(V) 1	T	I I V			ORF1b	1538		3' to 5' exonuclease	15									5941	N-terminal ExoN domain		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 1549
3'-to-5' exonuclease 26
Genomic 18115-18117"					18115	18115	18117	CAC(H)	TAC(Y) 2 2 TAC(Y) YAC(HY) 1	H	Y Y HY			ORF1b	1549		3' to 5' exonuclease	26									5952	N-terminal ExoN domain		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 1680
3'-to-5' exonuclease 157
Genomic 18508-18510"					18508	18508	18510	CTT(L)	TTT(F) 2	L	F			ORF1b	1680		3' to 5' exonuclease	157									6083	N-terminal ExoN domain		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 1728,3'-to-5' exonuclease 205"	0	1	na	0	18652	18652	18654	Cgc	Tgc	R	C	4	0	ORF1b	1728	ORF1a 6108	3'-to-5' exonuclease	205	na	na	na	na	na	na	na	na	6131	N-terminal ExoN domain		"10.1016/j.virusres.2017.01.023,1 0.3389/fmicb.2019.01813"
"ORF1b 1739,3'-to-5' exonuclease 216"	0	1	na	0	18685	18685	18687	Tgc	Cgc	C	R	12	0	ORF1b	1739	ORF1a 6119	3'-to-5' exonuclease	216	na	na	na	na	na	na	na	na	6142	"Partially conserved residue, N-terminal ExoN domain"		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 1756,3'-to-5' exonuclease 233"	0	2	na	0	18736	18736	18738	Ttt	Ctt	F	L	3	0	ORF1b	1756	ORF1a 5903	3'-to-5' exonuclease	233	na	na	na	na	na	na	na	na	5926	N-terminal ExoN domain		"10.1016/j.virusres.2017.01.023, 10.3389/fmicb.2019.01813"
"ORF1b 1762
3'-to-5' exonuclease 239
Genomic 18754-18756"					18754	18754	18756	CCG(P)	CCT(P) 2 1 CCG(P) GCG(A) 1 CCG(P) CCK(P) 1 CCA(P) CCG(P) 1	P	P P A P P P P			ORF1b	1762		3' to 5' exonuclease	239									5932	N-terminal ExoN domain		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 1803
3'-to-5' exonuclease 280
Genomic 18877-18879"					18877	18877	18879	CTA(L)	TTA(L) 17 2 CTA(L) YTA(L) 1	L	L L L			ORF1b	1803		3' to 5' exonuclease	280									5973	N-terminal ExoN domain		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 1838,3'-to-5' exonuclease 315"	0	0	0	0	18982	18982	18984	0	0	M	I	2	0	ORF1b	1838		3'-to-5' exonuclease	315	na	na	na	na	na	na	na	na	6008	C- terminal N7-methyl transferase domain		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 1894
3'-to-5' exonuclease 371
Genomic 19150-19152"					19150	19150	19152	GCC(A)	GTC(V) 1 1	A	V			ORF1b	1894		3' to 5' exonuclease	371									6064	C- terminal N7-methyl transferase domain		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 1974
3'-to-5' exonuclease 451
Genomic 19390-19392"					19390	19390	19392	CCA(P)	CCC(P) 1 CCA(P) CCG(P) 1 CCA(P) CNA(QPRL) 1 CCA(P) CTA(L) 1	P	P P P P QPRL P L			ORF1b	1974		3' to 5' exonuclease	451									6144	C- terminal N7-methyl transferase domain		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 2005
3'-to-5' exonuclease 482
Genomic 19483-19485"					19483	19483	19485	GCT(A)	GTT(V) 4 5 GCT(A) GNT(DAGV) 60 GNT(DAGV) GTT(V) 4 GCT(A) GYT(AV) 1	A	V A DAGV DAGV V A AV			ORF1b	2005		3' to 5' exonuclease	482									6175	C- terminal N7-methyl transferase domain		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 2123
endoRNAse 73
Genomic 19837-19839"					19837	19837	19839	AAC(N)	AAT(N) 4 2 AAT(N) AAY(N) 1 AAC(N) AAY(N) 1	N	N N N N N			ORF1b	2123		endoRNAse	73									6293	central domain		
"ORF1b 2142,endoRNAse 92"	0	2	na	0	19894	19894	19896	gaT	gaC	D	D	2	0	ORF1b	2142	ORF1a 6522	endoRNAse	92	na	na	na	na	na	na	na	na	6545	"uridine-specific endoribonuclease, EndoU uridylate-specific endoribonuclease, XendoU homolog, central domain"		"10.1016/j.virusres.2017.01.023, 10.1371/journal.ppat.1000428, 10.3389/fmicb.2019.01813, 10.1016/S0022-2836(03)00865-9, 10.1073/pnas.0601708103"
"ORF1b 2266
endoRNAse 216
Genomic 20266-20268"					20266	20266	20268	TTA(L)	TTG(L) 22 2 TTA(L) TTR(L) 1	L	L L L			ORF1b	2266		endoRNAse	216									6669	 C-terminal Domain		
"ORF1b 2269,endoRNAse 219"	0	3	na	0	20275	20275	20277	0	0	D	"N,Y,G"	2	0	ORF1b	2269	ORF1a 6649	endoRNAse	219	na	na	na	na	na	na	na	na	6672	"uridine-specific endoribonuclease, Mutation reported, wild type phenotype, EndoU uridylate-specific endoribonuclease, XendoU homolog, C-terminal Domain"		"10.1073/pnas.0601708103, 10.1371/journal.ppat.1000428, 10.3389/fmicb.2019.01813, 10.1016/S0022-2836(03)00865-9, 10.1073/pnas.0601708103"
"ORF1b 2457
2'-O-ribose methyltransferase 61
Genomic 20839-20841"					20839	20839	20841	GTA(V)	GTG(V) 1 GTA(V) GTT(V) 1	V	V V V			ORF1b	2457		2' O ribose methyltransferase	61									6860			
"ORF1b 2458
2'-O-ribose methyltransferase 62
Genomic 20842-20844"					20842	20842	20844	CCC(P)	CCT(P) 4 CCA(P) CCC(P) 1 CCC(P) CCY(P) 1	P	P P P P P			ORF1b	2458		2' O ribose methyltransferase	62									6861			
"ORF1b 2530
2'-O-ribose methyltransferase 134
Genomic 21058-21060"					21058	21058	21060	CCT(P)	TCT(S) 3	P	S			ORF1b	2530		2' O ribose methyltransferase	134									6933			
"ORF1b 2556,2'-O-ribose methyltransferase 160"	0	2	na	0	21136	21136	21138	aAg	aGg	K	R	4	0	ORF1b	2556	ORF1a 6936	2'-O-ribose methyltransferase	160	na	na	na	na	na	na	na	na	6959	core MTase domain		10.1371/journal.ppat.1002294
"ORF1b 2591,2'-O-ribose methyltransferase 195"	0	1	na	0	21241	21241	21243	0	0	T	I	5	0	ORF1b	2591	ORF1a 6971	2'-O-ribose methyltransferase	195	na	na	na	na	na	na	na	na	6994	core MTase domain		10.1371/journal.ppat.1002294
"ORF1b 2595
2'-O-ribose methyltransferase 199
Genomic 21253-21255"					21253	21253	21255	GCG(A)	GCT(A) 1 GCC(A) GCG(A) 2 GCG(A) GCN(A) 1 GCA(A) GCG(A) 1	A	A A A A A A A			ORF1b	2595		2' O ribose methyltransferase	199									6998			
"ORF1b 2612,2'-O-ribose methyltransferase 216"	1	2	na	0	21304	21304	21306	0	0	R	N	2	0	ORF1b	2612	ORF1a  6992	2'-O-ribose methyltransferase	216	na	na	na	na	na	na	na	na	7015			
S 29	0	1	na	0	21647	21647	21649	0	0	T	"I,S"	6	0	S	29	33	NL63 20		na	na	na	na	na	na	na	na		N-terminal Domain		
"S 61
Genomic 21743-21745"					21743	21743	21745	AAC(N)	AAT(N) 3	N	N			S	61	65												N-terminal Domain		
S 76	0	1	na	0	21788	21788	21790	0	0	T	I	6	0	S	76	-	NL63 -		na	na	na	na	na	na	na	na		N-terminal Domain		
S 95	0	1	na	0	21845	21845	21847	0	0	T	I	6	0	S	95	92	NL63 100		na	na	na	na	na	na	na	na		N-terminal Domain		
"S 138
Genomic 21974-21976"					21974	21974	21976	GAC(D)	GAT(D) 2 CAT(H) GAT(D) 2 GAT(D) RAT(ND) 1 GAN(ED) GAT(D) 1 GAT(D) TAT(Y) 1	D	D H D D ND ED D D Y			S	138	135														
S 144	0	2	na	0	21992	21992	21994	0	0	V	D	2	0	S	144	141	NL63 -		na	na	na	na	na	na	na	na				
"S 231
Genomic 22253-22255"					22253	22253	22255	ACC(T)	ATA(I) 1	T	I			S	231	224														
"S 294
Genomic 22442-22444"					22442	22442	22444	GAC(D)	GAT(D) 2 2 GAC(D) GNC(DAGV) 3 GAC(D) NNN(-) 2 GAC(D) GAN(ED) 1	D	D D DAGV D - D ED			S	294	281														
S 367	0	2	na	0	22661	22661	22663	gtC	gtT	V	V	12	0	S	367	354	NL63 508		na	na	na	na	na	na	na	na		RBD		
S 439	0	1	na	0	22877	22877	22879	0	0	N	K	4	0	S	439	426	NL63 557		na	na	na	na	na	na	na	na		"RBD, RBM, Variable residues between SARS-CoV-2 and SARS-CoV, critical residues in Polyclonal anti-SARS-1 antibodies and different between SARS-CoV-2 and SARS-CoV RBDs, ACE2-binding residue, SARS-CoV-derived discontinuous B cell epitopes associated with antibody m396"	"Could impact Response to antibodies, Residue reported to decrease ACE2 Binding when mutated in SARS"	"10.1038/s41423-020-0400-4, 10.1038/s41467-020-15562-9, doi.org/10.1038/s41423-020-0374-2, 10.1186/1743-422X-2-73, 10.1126/science.abb7269, 10.3390/v12030254"
"S 598
Genomic 23354-23356"					23354	23354	23356	ATA(I)	ATT(I) 1	I	I			S	598	584												"HLA-DRB1*01:01, B cell epitope region"		"10.3390/v12030254, 10.1016/j.chom.2020.03.002"
S 614	0	3	na	0	23402	23402	23404	0	0	G	D	12	0	S	614	600	NL63 702		na	na	na	na	na	na	na	na		"B cell epitope region, North America Mutation, other mutations more likely to appear"		"10.1016/j.chom.2020.03.002, 10.1016/j.ygeno.2020.04.016, "
"S 620
Genomic 23420-23422"					23420	23420	23422	GTC(V)	GTT(V) 1 2 GTA(V) GTC(V) 1 GTC(V) GTY(V) 1	V	V V V V V			S	620	606												B cell epitope region		10.1016/j.chom.2020.03.002
"S 623
Genomic 23429-23431"					23429	23429	23431	GCT(A)	TCT(S) 1 GCT(A) GTT(V) 1	A	S A V			S	623	609												B cell epitope region		10.1016/j.chom.2020.03.002
"S 675
Genomic 23585-23587"					23585	23585	23587	CAC(H)	CAG(Q) 1 CAG(Q) CGG(R) 1 CAG(Q) CAT(H) 1 AAG(K) CAG(Q) 1	H	Q Q R Q H K Q			S	675	661														
"S 723
Genomic 23729-23731"					23729	23729	23731	ACC(T)	ACT(T) 7 2 ACC(T) ATC(I) 1 ACC(T) ACY(T) 1	T	T T I T T			S	723	705												T Cell Epitopes		10.1016/j.chom.2020.03.002
S 731	0	1	na	0	23753	23753	23755	atG	"atC,atT"	M	"I,I"	2	0	S	731	713	NL63 782		na	na	na	na	na	na	na	na				
"S 824
Genomic 24032-24034"					24032	24032	24034	AAC(N)	AAT(N) 5 3 AAT(N) AAY(N) 2 AAC(N) AAY(N) 1 AAC(N) AGC(S) 1	N	N N N N N N S			S	824	806												B cell epitope region		10.1016/j.chom.2020.03.002
"S 934
Genomic 24362-24364"					24362	24362	24364	ATC(I)	ATT(I) 1 ATA(I) ATC(I) 1 ATG(M) ATT(I) 1	I	I I I M I			S	934	916														
S 943	0	2	na	0	24389	24389	24391	0	0	S	"P,T"	12	0	S	943	925	NL63 1009		na	na	na	na	na	na	na	na		"T cell epitope, Epitope HLA locus A group 2 subtype 2:01, “HR1”, Fusion Core :  target of fusion/entry inhibitors, One of the 8 residues that differs from SARS-Cov Fusion Core , position f in the heptad repeat abcdefg pattern, "	"T variant more similar to SARS-1 fusion Core, Change in impact of fusion/entry inhibitor drugs, little to no impact expected on HR structure"	"10.1101/2020.03.30.016931, 10.1016/j.chom.2020.03.002, 10.1038/s41423-020-0374-2,10.1016/j.virol.2005.02.022, 10.1016/S0140-6736(04)15788-7"
"S 1044
Genomic 24692-24694"					24692	24692	24694	GGA(G)	GGT(G) 3 1 GGA(G) GGM(G) 1	G	G G G			S	1044	1026												"HLA-B*15:01, HLA-B*27:05, HLA-B*58:01, HLA-C*15:02,  T Cell Epitopes"		"10.3390/v12030254, 10.1016/j.chom.2020.03.002"
"S 1100
Genomic 24860-24862"					24860	24860	24862	ACA(T)	ACG(T) 2 1	T	T			S	1100	1082												HLA-DRB1*01:01		10.3390/v12030254
ORF3a 14	0	1	na	0	25432	25432	25434	0	0	T	I	10	0	ORF3a	14	14	na		na	na	na	na	na	na	na	na		" T cell epitope, Epitope HLA locus B group 2 58:01:00"	Deleterious Mutation 	"10.1101/2020.03.30.016931, 10.1016/j.chom.2020.03.002, 10.1128/mSystems.00266-20"
"ORF3a 42
Genomic 25516-25518"					25516	25516	25518	CCT(P)	CTT(L) 1 CCT(P) TCT(S) 1 CTT(L) CYT(PL) 1 CCT(P) NNN(-) 1 CCT(P) MCT(TP) 1 CCT(P) CNT(HPRL) 1	P	L P S L PL P - P TP P HPRL			ORF3a	42															
"ORF3a 43
Genomic 25519-25521"					25519	25519	25521	TTC(F)	TTT(F) 3 1 TTC(F) TTY(F) 3 TTC(F) YTC(LF) 2 ATC(I) TTC(F) 1 NNN(-) TTT(F) 1 TTT(F) TTY(F) 1	F	F F F F LF I F - F F F			ORF3a	43															
ORF3a 54	0	1	na	0	25552	25552	25554	0	0	A	"S,V,T"	6	0	ORF3a	54	54	na	na	na	na	na	na	na	na	na	na			Neutral mutation	10.1128/mSystems.00266-20
ORF3a 57	0	1	na	0	25561	25561	25563	caG	"caA,caT"	Q	"Q,H"	7	0	ORF3a	57	57	na	na	na	na	na	na	na	na	na	na				
"ORF3a 68
Genomic 25594-25596"					25594	25594	25596	AGA(R)	ATA(I) 1 AGA(R) AGG(R) 1 AGA(R) CGA(R) 1 AGA(R) AKA(RI) 1	R	I R R R R R RI			ORF3a	68															
ORF3a 86	0	0	0	0	25648	25648	25650	0	0	L	F	4	0	ORF3a	86	86	na	na	na	na	na	na	na	na	na	na		"Cystein rich domain,"		"10.1016/j.antiviral.2014.06.013,"
ORF3a 95	0	1	na	0	25675	25675	25677	0	0	L	"F,S"	2	0	ORF3a	95	95	na	na	na	na	na	na	na	na	na	na		"Cystein rich domain, K+ ion channel"		"10.1016/j.antiviral.2014.06.013, 10.1128/mSystems.00266-20"
ORF3a 99	0	1	na	0	25687	25687	25689	Ggc	Agc	G	S	12	0	ORF3a	99	99	na	na	na	na	na	na	na	na	na	na		"Cystein rich domain, K+ ion channel"	Neutral mutation	"10.1016/j.antiviral.2014.06.013, 10.1128/mSystems.00266-20, 10.1128/mSystems.00266-20"
ORF3a 107	0	1	na	0	25711	25711	25713	cTt	cCt	L	P	2	0	ORF3a	107	107	na	na	na	na	na	na	na	na	na	na		"Cystein rich domain, K+ ion channel"		"10.1016/j.antiviral.2014.06.013, 10.1128/mSystems.00266-20"
ORF3a 110	0	1	na	0	25720	25720	25722	0	0	A	"S,P,V"	3	0	ORF3a	110	110	na	na	na	na	na	na	na	na	na	na		"Cystein rich domain, K+ ion channel"		"10.1016/j.antiviral.2014.06.013, 10.1128/mSystems.00266-20"
ORF3a 125	0	1	na	0	25765	25765	25767	0	0	M	I	3	0	ORF3a	125	125	na	na	na	na	na	na	na	na	na	na		"Cystein rich domain, central region, bind to 5’UTR of SAR-Cov genome, K+ ion channel"	Neutral	"10.1016/j.antiviral.2014.06.013, 10.1128/mSystems.00266-20"
ORF3a 131	0	0	0	0	25783	25783	25785	0	0	W	"C,L"	4	0	ORF3a	131	131	na	na	na	na	na	na	na	na	na	na		"Cystein rich domain, , CWLCWKC region"	Deleterious	"10.1016/j.antiviral.2014.06.013, 10.1128/mSystems.00266-20"
ORF3a 140	0	0	0	0	25810	25810	25812	0	0	L	"F,V"	4	0	ORF3a	140	140	na	na	na	na	na	na	na	na	na	na		"Cystein rich domain,"	Neutral	10.1128/mSystems.00266-20
ORF3a 144	0	1	na	0	25822	25822	25824	0	0	N	D	4	0	ORF3a	144	144	na	na	na	na	na	na	na	na	na	na		"Cystein rich domain, central region, bind to 5’UTR of SAR-Cov genome, caveolin-binding motif"		10.1016/j.antiviral.2014.06.013
ORF3a 147	0	1	na	0	25831	25831	25833	0	0	L	F	5	0	ORF3a	147	147	na	na	na	na	na	na	na	na	na	na		"Cystein rich domain, central region, bind to 5’UTR of SAR-Cov genome, caveolin-binding motif"		10.1016/j.antiviral.2014.06.013
ORF3a 184	0	0	0	0	25942	25942	25944	0	0	Y	H	8	0	ORF3a	184	184	na	na	na	na	na	na	na	na	na	na				
ORF3a 223	0	1	na	0	26059	26059	26061	0	0	T	I	5	0	ORF3a	223	223	na	na	na	na	na	na	na	na	na	na		"C-ter domaine : induce cell cycle arrest, potential cytoplasmic region"		10.1016/j.antiviral.2014.06.013
ORF3a 239	0	2	na	0	26107	26107	26109	0	0	E	"D,G,V"	2	0	ORF3a	239	239	na	na	na	na	na	na	na	na	na	na		"C-ter domaine : induce cell cycle arrest, potential cytoplasmic region"		"10.1016/j.antiviral.2014.06.013,10.1016/j.jmb.2004.06.016"
ORF3a 251	0	2	na	0	26143	26143	26145	0	0	G	"V,C"	12	0	ORF3a	251	250	na	na	na	na	na	na	na	na	na	na		"C-ter domaine : induce cell cycle arrest, Identified mutation, potential cytoplasmic region"	Deleterious Mutation (both)	"10.1016/j.antiviral.2014.06.013,10.1016/j.jmb.2004.06.016, 10.1128/mSystems.00266-20, 10.1186/s12967-020-02344-6, 10.1016/j.ygeno.2020.04.016, "
ORF3a 254	0	1	na	0	26152	26152	26154	0	0	G	R	3	0	ORF3a	254	253	na	na	na	na	na	na	na	na	na	na		"C-ter domaine : induce cell cycle arrest, potential cytoplasmic region"	Deleterious Mutation 	"10.1016/j.antiviral.2014.06.013,10.1016/j.jmb.2004.06.016, 10.1128/mSystems.00266-20"
ORF3a 271	0	0	0	0	26203	26203	26205	0	0	T	I	4	0	ORF3a	271	271	na	na	na	na	na	na	na	na	na			C-ter domaine : induce cell cycle arrest		"10.1016/j.antiviral.2014.06.013,10.1016/j.jmb.2004.06.016, 10.1128/mSystems.00266-20"
"M 30
Genomic 26610-26612"					26610	26610	26612	ACA(T)	ACG(T) 1 ACG(T) ACT(T) 1	T	T T T			M	30	29														
"M 69
Genomic 26727-26729"					26727	26727	26729	GCC(A)	GCT(A) 6 1 GCT(A) TCT(S) 1 GCT(A) KCT(AS) 1 GCT(A) GCY(A) 1 GCC(A) GCY(A) 1	A	A A S A AS A A A A			M	69	68												T Cell Epitopes		10.1016/j.chom.2020.03.002
"M 109
Genomic 26847-26849"					26847	26847	26849	ATG(M)	ATT(I) 1 ATC(I) ATT(I) 1 ATG(M) ATN(IM) 1	M	I I I M IM			M	109	108														
"M 132
Genomic 26916-26918"					26916	26916	26918	CCG(P)	GCG(A) 1 CCG(P) CCK(P) 1 CCA(P) CCG(P) 1 CCG(P) CCT(P) 1 CCC(P) CCG(P) 1	P	A P P P P P P P P			M	132	131														
"M 141
Genomic 26943-26945"					26943	26943	26945	GGA(G)	GGT(G) 1 GGT(G) NGG(RGW) 1	G	G G RGW			M	141	140												B cell epitope region		10.1016/j.chom.2020.03.002
"M 143
Genomic 26949-26951"					26949	26949	26951	GTG(V)	GTT(V) 2 GTA(V) GTG(V) 2 GTG(V) GTK(V) 1 GNS(MIX) GTG(V) 1	V	V V V V V MIX V			M	143	142												B cell epitope region		10.1016/j.chom.2020.03.002
M 175	0	1	na	0	27045	27045	27047	0	0	T	"M,A"	8	0	M	175	174	na	na	na	na	na	na	na	na	na	na		"N Binding region, known mutation"		"10.1007/s11373-005-9035-9, 10.1016/j.ygeno.2020.04.016"
M 209	0	1	na	0	27147	27147	27149	0	0	D	"H,Y"	12	0	M	209	208	na	na	na	na	na	na	na	na	na	na				
ORF6 12	1	0	0	0	27147	27235	27237	0	0	A	T	9	0	ORF6	12		na	na	na	na	na	na	na	na	na	na				
ORF6 61	1	0	0	0	27235	27382	27384	gaT	gaC	D	D	2	0	ORF6	61		na	na	na	na	na	na	na	na	na	na				
"ORF7a 70
Genomic 27601-27603"					27601	27601	27603	GGC(G)	GGT(G) 1 1 GGC(G) TGC(C) 1 GGA(G) GGT(G) 1	G	G G C G G			ORF7a	70															
"ORF7a 92
Genomic 27667-27669"					27667	27667	27669	GAA(E)	GAG(E) 1 GAG(E) GAR(E) 1 GAG(E) GAT(D) 1	E	E E E E D			ORF7a	92															
"ORF7a 121
Genomic 27754-27756"					27754	27754	27756	GAA(E)	GAW(ED) 1 GAA(E) GAG(E) 1	E	ED E E			ORF7a	121															
ORF8 51	0	1	na	0	28044	28044	28046	aGa	aTa	R	I	4	0	ORF8	51		na	na	na	na	na	na	na	na	na	na				
ORF8 65	0	2	na	0	28086	28086	28088	Ggt	Tgt	G	C	9	0	ORF8	65		na	na	na	na	na	na	na	na	na	na				
ORF8 67	0	1	na	0	28092	28092	28094	0	0	S	F	4	0	ORF8	67		na	na	na	na	na	na	na	na	na	na				
ORF8 84	0	1	na	0	28143	28143	28145	ttA	ttT	L	F	11	0	ORF8	84		na	na	na	na	na	na	na	na	na	na		Identified mutation		"10.1186/s12967-020-02344-6, 10.1016/j.ygeno.2020.04.016"
ORF8 85	0	1	na	0	28146	28146	28148	0	0	P	S	2	0	ORF8	85		na	na	na	na	na	na	na	na	na	na				
ORF8 121	1	3	na	0	28254	28254	28256	0	0	I	"L,S"	8	0	ORF8	121		na	na	na	na	na	na	na	na	na	na				
N 13	0	2	na	0	28310	28310	28312	Cgc	Ggc	R	G	9	0	N	13	14	na	na	na	na	na	na	na	na	na	na				
N 20	0	1	na	0	28331	28331	28333	0	0	P	"S,L"	5	0	N	20	22	na	na	na	na	na	na	na	na	na	na				
N 22	0	1	na	0	28337	28337	28339	0	0	D	"G,Y"	9	0	N	22	23	na	na	na	na	na	na	na	na	na	na				
N 24	0	1	na	0	28343	28343	28345	Ggc	Tgc	G	C	6	0	N	24	25	na	na	na	na	na	na	na	na	na	na				
N 34	0	2	na	0	28373	28373	28375	0	0	G	"E,W"	10	0	N	34	35	na	na	na	na	na	na	na	na	na	na				
N 36	0	1	na	0	28379	28379	28381	0	0	R	L	2	0	N	36	37	na	na	na	na	na	na	na	na	na	na				
"N 55
Genomic 28436-28438"					28436	28436	28438	GCT(A)	TCT(S) 1	A	S			N	55	56												B cell epitope region		10.1016/j.chom.2020.03.002
N 67	0	1	na	0	28472	28472	28474	0	0	P	"T,S"	7	0	N	67	68	na	na	na	na	na	na	na	na	na	na		"linker region (LKR), U-shaped β-platform, putative RNA- binding domain, B-cell epitope   HLA-A*02:01 HLA-B*07:02 HLA-B*08:01 HLA-B*35:01 HLA-B*51:01 (identical in SARS-CoV-2 and SARS-Cov)"		"10.1128/jvi.00017-07 ,10.1016/j.jmb.2007.02.069, 10.3390/v12030254"
N 108	0	0	0	0	28595	28595	28597	0	0	W	C	6	0	N	108		na	na	na	na	na	na	na	na	na	na		"B-cell epitope  HLA-A*24:02, HLA-A*03:01,  HLA-A*11:01 HLA-A*68:01 HLA-A*23:01 HLA-A*31:01 (identical in SARS-CoV-2 and SARS-Cov)"		10.3390/v12030254
N 119	0	1	na	0	28628	28628	28630	gGa	gTa	G	V	7	0	N	119	120	na	na	na	na	na	na	na	na	na	na		"linker region (LKR), U-shaped β-platform, putative RNA- binding domain"		"10.1128/jvi.00017-07, 10.1016/j.jmb.2007.02.069"
"N 139
Genomic 28688-28690"					28688	28688	28690	CTG(L)	TTG(L) 2 3 TTG(L) TTT(F) 1 1 TTG(L) YTG(L) 3 CTG(L) YTG(L) 1 TTK(LF) TTT(F) 1	L	L L F L L L L LF F			N	139	140														
N 144	0	1	na	0	28703	28703	28705	0	0	D	"N,E,H,Y"	7	0	N	144	145	na	na	na	na	na	na	na	na	na	na		"linker region (LKR), U-shaped β-platform, T cell epitope, possible RNA binding , B-cell epitope HLA-A*02:01 HLA-A*11:01 HLA-A*68:01 HLA-A*31:01, T-cell epitope  HLA-A*02:01 (identical in SARS-CoV-2 and SARS-Cov)"		"10.1016/j.chom.2020.03.002 10.1128/jvi.00017-07, 10.1016/j.str.2005.08.021, 10.1016/j.jmb.2007.02.069, 10.3390/v12030254"
N 151	0	1	na	0	28724	28724	28726	Gct	Tct	A	S	7	0	N	151	152	na	na	na	na	na	na	na	na	na	na		"linker region (LKR), U-shaped β-platform, putative RNA- binding domain"		"10.1128/jvi.00017-07, 10.1016/j.jmb.2007.02.069"
"N 173
Genomic 28790-28792"					28790	28790	28792	GCA(A)	GCG(A) 1 GCA(A) GTA(V) 1 GCG(A) GCT(A) 1 GCA(A) GCN(A) 1	A	A A V A A A A			N	173	174														
N 180	0	1	na	0	28811	28811	28813	0	0	S	"I,C,G"	4	0	N	180	181	na	na	na	na	na	na	na	na	na	na		"linker region (LKR), U-shaped β-platform, putative RNA- binding domain; B-cell epitope HLA-A*33:01 HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 (identical in SARS-CoV-2 and SARS-Cov)"		"10.1128/jvi.00017-07, 10.1016/j.jmb.2007.02.069, 10.3390/v12030254"
N 185	0	1	na	0	28826	28826	28828	0	0	R	"C,L,H"	3	0	N	185	186	na	na	na	na	na	na	na	na	na	na		"linker region (LKR), U-shaped β-platform, essential for multimerization of SARS-CoV N protein, Phosphorylation site in IBV, B-cell epitope HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 (identical in SARS-CoV-2 and SARS-Cov)"		"10.1128/jvi.00017-07, 10.1016/j.str.2005.08.021, 10.1007/s11373-005-9035-9, 10.3390/v12030254"
N 190	0	1	na	0	28841	28841	28843	0	0	S	"I,G"	8	0	N	190	191	na	na	na	na	na	na	na	na	na	na		"linker region (LKR), U-shaped β-platform, essential for multimerization of SARS-CoV N protein, Phosphorylation site in IBV, B-cell epitope HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 HLA-A*33:01 (identical in SARS-CoV-2 and SARS-Cov)"		"10.1128/jvi.00017-07, 10.1016/j.str.2005.08.021, 10.1007/s11373-005-9035-9, 10.3390/v12030254"
N 202	0	1	na	0	28877	28877	28879	aGg	aAg	R	K	9	0	N	202	203	na	na	na	na	na	na	na	na	na	na		"linker region (LKR), "		10.1128/jvi.00017-07
N 205	0	1	na	0	28886	28886	28888	0	0	T	I	5	0	N	205	206	na	na	na	na	na	na	na	na	na	na		"linker region (LKR), "		10.1128/jvi.00017-07
N 208	0	1	na	0	28895	28895	28897	0	0	A	G	7	0	N	208	209	na	na	na	na	na	na	na	na	na	na		"linker region (LKR), "		10.1128/jvi.00017-07
N 215	0	1	na	0	28916	28916	28918	0	0	G	S	2	0	N	215	216	na	na	na	na	na	na	na	na	na	na		"linker region (LKR), T cell epitope"		"10.1016/j.chom.2020.03.002, 10.1128/jvi.00017-07"
N 218	0	1	na	0	28925	28925	28927	0	0	A	"V,S"	4	0	N	218	219	na	na	na	na	na	na	na	na	na	na		"linker region (LKR), T cell epitope"		"10.1016/j.chom.2020.03.002, 10.1128/jvi.00017-07"
"N 253
Genomic 29030-29032"					29030	29030	29032	GAA(E)	GAG(E) 1 1 GAG(E) GGG(G) 1 GAG(E) GAT(D) 1 GAG(E) GAK(ED) 1 GAG(E) GNG(EAGV) 1	E	E E G E D E ED E EAGV			N	253	254														
"N 291
Genomic 29144-29146"					29144	29144	29146	CTA(L)	TTA(L) 3 1 CTA(L) YTA(L) 1	L	L L L			N	291	292														
"N 305
Genomic 29186-29188"					29186	29186	29188	GCA(A)	GCT(A) 1 1 GCA(A) GYR(AV) 4 ---(-) GCA(A) 1	A	A A AV ---(-) A			N	305	306														
"N 318
Genomic 29225-29227"					29225	29225	29227	TCG(S)	TCT(S) 2 TCA(S) TCG(S) 2	S	S S S			N	318	319												T Cell Epitopes		10.1016/j.chom.2020.03.002
N 336	0	1	na	0	29279	29279	29281	0	0	A	V	5	0	N	336	337	na	na	na	na	na	na	na	na	na	na		"CTD, hydrophobic, helix-rich terminal, dimerization do- main, core stabilized by multiple hydrophobic interactions"		"10.1128/jvi.00017-07, 10.1016/j.jmb.2007.02.069"
N 344	0	2	na	0	29303	29303	29305	0	0	P	"S,L"	2	0	N	344	345	na	na	na	na	na	na	na	na	na	na		"CTD, hydrophobic, helix-rich terminal, dimerization do- main, core stabilized by multiple hydrophobic interactions"		"10.1128/jvi.00017-07, 10.1016/j.jmb.2007.02.069"
N 348	0	1	na	0	29315	29315	29317	0	0	D	"Y,H"	2	0	N	348	349	na	na	na	na	na	na	na	na	na	na		"CTD, hydrophobic, helix-rich terminal, T cell epitope, Epitope HLA locus A subtype  24:02:00, dimerization do- main, core stabilized by multiple hydrophobic interactions, extended b-strand"		"10.1101/2020.03.30.016931, 10.1016/j.chom.2020.03.002, 10.1128/jvi.00017-07, 10.1016/j.jmb.2007.02.069, 10.1007/s11373-005-9035-9"
"N 360
Genomic 29351-29353"					29351	29351	29353	TAC(Y)	TAT(Y) 4 1	Y	Y			N	360													B cell epitope region		10.1016/j.chom.2020.03.002
N 368	0	1	na	0	29375	29375	29377	0	0	P	S	2	0	N	368	369	na	na	na	na	na	na	na	na	na	na		"B cell epitope region, Epitope HLA locus A subtype 11:01, core stabilized by multiple hydrophobic interactions, RNA binding region, Phosphorylation site in IBV, B-cell epitope  HLA-A*03:01 HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 HLA-DRB1*01:01 (identical in SARS-CoV-2 and SARS-Cov)"		"10.1101/2020.03.30.016931, 10.1016/j.chom.2020.03.002, 10.1016/j.jmb.2007.02.069, 10.1007/s11373-005-9035-9, 0.3390/v12030254"
N 393	0	1	na	0	29450	29450	29452	acT	acC	T	T	4	0	N	393	394	na	na	na	na	na	na	na	na	na	na		"B cell epitope region, Phosphorylation site in IBV"		"10.1016/j.chom.2020.03.002, 10.1007/s11373-005-9035-9"
"N 397
Genomic 29462-29464"					29462	29462	29464	GCT(A)	GTT(V) 1 GCT(A) TCT(S) 1 GNT(DAGV) GTT(V) 1	A	V A S DAGV V			N	397	398												B cell epitope region		10.1016/j.chom.2020.03.002
N 399	0	1	na	0	29468	29468	29470	0	0	D	Y	3	0	N	399	400	na	na	na	na	na	na	na	na	na	na		B cell epitope region		10.1016/j.chom.2020.03.002
N 402	0	1	na	0	29477	29477	29479	0	0	D	Y	6	0	N	402	403	na	na	na	na	na	na	na	na	na	na				
"N 417
Genomic 29522-29524"					29522	29522	29524	ACT(T)	ATT(I) 1	T	I			N	417															